Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

Also called NCT06177808

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06177808
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06177808. Randomized; no masking; primary purpose treatment. Start 2024-01-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS)
Intervention (Device)
Wolverine cutting balloon
Intervention (Device)
Non-compliant balloon
Lead sponsor
Soonchunhyang University Hospital (class: other)
Collaborator
Boston Scientific Corporation (class: industry)
Collaborator
Eulji University (class: other)
Collaborator
The Catholic University of Korea (class: other)
Collaborator
Hanil General Hospital, Korea (class: not stated)

Record details

Record id
cardio:ct-nct06177808
Content hash
b330d37c12fc1ad77798827c3f63e7662e969de2fe0a6b2c54bf3f68e82c3f86